Harte Hanks Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Harte Hanks has been growing earnings at an average annual rate of 40.3%, while the Media industry saw earnings growing at 8.7% annually. Revenues have been declining at an average rate of 2.1% per year.
Anahtar bilgiler
40.3%
Kazanç büyüme oranı
42.0%
EPS büyüme oranı
| Media Sektör Büyümesi | 13.2% |
| Gelir büyüme oranı | -2.1% |
| Özkaynak getirisi | -142.5% |
| Net Marj | -15.7% |
| Sonraki Kazanç Güncellemesi | 14 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues
Jul 03
With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case
Nov 03Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price
Oct 13Harte Hanks (NASDAQ:HHS) Is Experiencing Growth In Returns On Capital
Jun 08Should You Investigate Harte Hanks, Inc. (NASDAQ:HHS) At US$8.83?
Mar 16Does Harte Hanks (NASDAQ:HHS) Deserve A Spot On Your Watchlist?
Feb 22Are Investors Undervaluing Harte Hanks, Inc. (NASDAQ:HHS) By 22%?
Dec 07If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity
Oct 27Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)
Sep 27Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger
Sep 19Harte Hanks and FEVO announce expanding partnership
Sep 15Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors
Aug 23Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market
Aug 13Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M
Aug 11What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?
Jul 26Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential
Jul 14Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock
May 23Gelir ve Gider Dağılımı
Harte Hanks nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 187 | -29 | 21 | 0 |
| 31 Mar 24 | 190 | -1 | 21 | 0 |
| 31 Dec 23 | 191 | -2 | 21 | 0 |
| 30 Sep 23 | 197 | 23 | 17 | 0 |
| 30 Jun 23 | 204 | 29 | 22 | 0 |
| 31 Mar 23 | 204 | 32 | 22 | 0 |
| 31 Dec 22 | 206 | 35 | 22 | 0 |
| 30 Sep 22 | 203 | 14 | 21 | 0 |
| 30 Jun 22 | 199 | 12 | 20 | 0 |
| 31 Mar 22 | 200 | 17 | 19 | 0 |
| 31 Dec 21 | 195 | 13 | 18 | 0 |
| 30 Sep 21 | 190 | 12 | 20 | 0 |
| 30 Jun 21 | 188 | 7 | 20 | 0 |
| 31 Mar 21 | 180 | -8 | 20 | 0 |
| 31 Dec 20 | 177 | -2 | 22 | 0 |
| 30 Sep 20 | 182 | -6 | 20 | 0 |
| 30 Jun 20 | 186 | -11 | 21 | 0 |
| 31 Mar 20 | 199 | -9 | 23 | 0 |
| 31 Dec 19 | 218 | -27 | 24 | 0 |
| 30 Sep 19 | 235 | -22 | 25 | 0 |
| 30 Jun 19 | 248 | -26 | 30 | 0 |
| 31 Mar 19 | 263 | -28 | 32 | 0 |
| 31 Dec 18 | 285 | 15 | 34 | 0 |
| 30 Sep 18 | 314 | -16 | 39 | 0 |
| 30 Jun 18 | 345 | -8 | 38 | 0 |
| 31 Mar 18 | 370 | -5 | 39 | 0 |
| 31 Dec 17 | 384 | -42 | 40 | 0 |
| 30 Sep 17 | 394 | -85 | 40 | 0 |
| 30 Jun 17 | 397 | -86 | 43 | 0 |
| 31 Mar 17 | 400 | -90 | 43 | 0 |
| 31 Dec 16 | 404 | -90 | 45 | 0 |
| 30 Sep 16 | 411 | -18 | 47 | 0 |
| 30 Jun 16 | 423 | -188 | 46 | 0 |
| 31 Mar 16 | 434 | -187 | 45 | 0 |
| 31 Dec 15 | 444 | -181 | 45 | 0 |
| 30 Sep 15 | 474 | -170 | 46 | 0 |
| 30 Jun 15 | 499 | 9 | 47 | 0 |
| 31 Mar 15 | 530 | 22 | 51 | 0 |
| 31 Dec 14 | 499 | 14 | 43 | 0 |
| 30 Sep 14 | 559 | 21 | 53 | 0 |
| 30 Jun 14 | 560 | 19 | 53 | 0 |
| 31 Mar 14 | 560 | 20 | 53 | 0 |
| 31 Dec 13 | 560 | 24 | 55 | 0 |
Kaliteli Kazançlar: HHS is currently unprofitable.
Büyüyen Kar Marjı: HHS is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: HHS is unprofitable, but has reduced losses over the past 5 years at a rate of 40.3% per year.
Büyüme Hızlandırma: Unable to compare HHS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: HHS is unprofitable, making it difficult to compare its past year earnings growth to the Media industry (4.5%).
Özkaynak Getirisi
Yüksek ROE: HHS has a negative Return on Equity (-142.49%), as it is currently unprofitable.